Sera Prognostics, Inc. (NASDAQ:SERA) Q4 2022 Earnings Call Transcript

So, it’s variable. It depends on what their interests are. It depends — for some systems, it depends on what they’re experiencing with regard to prematurity. If they have extremely high complications — high rate of complications occurring in the population that they’re insuring. And it’s a pain point for them. They are oftentimes more apt to want to move forward sooner. It’s really variable if you look across all sorts of payers.

Francois Brisebois: Understood. That’s very helpful. Thank you.

Operator: . Seeing no further questions in the queue, I would like to turn the call back over to Mr. Peter DeNardo for any closing remarks.

Peter DeNardo: Thank you, MJ. This concludes the call. We look forward to providing an update on our business when we report first quarter 2023 financial results. Thank you, and good afternoon, everyone.

Operator: The conference has now concluded. Thank you for attending today’s presentation. You may now disconnect.